Drug Profile
JNJ 49122944
Alternative Names: JNJ-49122944Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Janssen Research & Development
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Undefined(In volunteers) in Belgium (IV, Infusion)
- 29 Oct 2014 Janssen Research & Development plans a phase I trial in Healthy volunteers in Belgium (NCT02280018)